Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares were up 6.3% on Thursday . The stock traded as high as $1.19 and last traded at $1.18. Approximately 243,487 shares traded hands during trading, an increase of 263% from the average daily volume of 67,097 shares. The stock had previously closed at $1.11.
Cardiol Therapeutics Price Performance
The company’s fifty day moving average price is $1.30 and its 200 day moving average price is $1.67.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- How to Choose Top Rated Stocks
- 5 Best Gold ETFs for March to Curb Recession Fears
- Following Congress Stock Trades
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- What Are Earnings Reports?
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
